{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T13:49:45Z","timestamp":1795009785173,"version":"4.9.1"},"reference-count":149,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:sec>\n                    <jats:title>Purpose of review<\/jats:title>\n                    <jats:p>Primary mitochondrial disease is a highly heterogeneous but collectively common inherited metabolic disorder, affecting at least one in 4300 individuals. Therapeutic management of mitochondrial disease typically involves empiric prescription of enzymatic cofactors, antioxidants, and amino acid and other nutrient supplements, based on biochemical reasoning, historical experience, and consensus expert opinion. As the field continues to rapidly advance, we review here the preclinical and clinical evidence, and specific dosing guidelines, for common mitochondrial medicine therapies to guide practitioners in their prescribing practices.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Recent findings<\/jats:title>\n                    <jats:p>Since publication of Mitochondrial Medicine Society guidelines for mitochondrial medicine therapies management in 2009, data has emerged to support consideration for using additional therapeutic agents and discontinuation of several previously used agents. Preclinical animal modeling data have indicated a lack of efficacy for vitamin C as an antioxidant for primary mitochondrial disease, but provided strong evidence for vitamin E and N-acetylcysteine. Clinical data have suggested L-carnitine may accelerate atherosclerotic disease. Long-term follow up on L-arginine use as prophylaxis against or acute treatment for metabolic strokes has provided more data supporting its clinical use in individuals with mitochondrial encephalopathy with lactic acidosis and stroke-like episodes (MELAS) syndrome and Leigh syndrome. Further, several precision therapies have been developed for specific molecular causes and\/or shared clinical phenotypes of primary mitochondrial disease.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Summary<\/jats:title>\n                    <jats:p>We provide a comprehensive update on mitochondrial medicine therapies based on current evidence and our single-center clinical experience to support or refute their use, and provide detailed dosing guidelines, for the clinical management of mitochondrial disease. The overarching goal of empiric mitochondrial medicines is to utilize therapies with favorable benefit-to-risk profiles that may stabilize and enhance residual metabolic function to improve cellular resiliency and slow clinical disease progression and\/or prevent acute decompensation.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/mop.0000000000000954","type":"journal-article","created":{"date-parts":[[2020,10,26]],"date-time":"2020-10-26T14:16:35Z","timestamp":1603721795000},"page":"707-718","source":"Crossref","is-referenced-by-count":102,"title":["Mitochondrial medicine therapies: rationale, evidence, and dosing guidelines"],"prefix":"10.1097","volume":"32","author":[{"given":"Isabella","family":"Barcelos","sequence":"first","affiliation":[{"name":"Center for Applied Genomics, Division of Human Genetics, Department of Pediatrics"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward","family":"Shadiack","sequence":"additional","affiliation":[{"name":"Mitochondrial Medicine Frontier Program, Division of Human Genetics, Department of Pediatrics, Children's Hospital of Philadelphia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca D.","family":"Ganetzky","sequence":"additional","affiliation":[{"name":"Mitochondrial Medicine Frontier Program, Division of Human Genetics, Department of Pediatrics, Children's Hospital of Philadelphia"},{"name":"Department of Pediatrics, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marni J.","family":"Falk","sequence":"additional","affiliation":[{"name":"Mitochondrial Medicine Frontier Program, Division of Human Genetics, Department of Pediatrics, Children's Hospital of Philadelphia"},{"name":"Department of Pediatrics, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2020,10,23]]},"reference":[{"key":"R1-20230918","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1016\/S0140-6736(18)30727-X","article-title":"Mitochondrial medicine in the omics era","volume":"391","author":"Rahman","year":"2018","journal-title":"Lancet (London, England)"},{"key":"R3-20230918","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1002\/ajmg.1391","article-title":"Clinical spectrum and diagnosis of mitochondrial disorders","volume":"106","author":"Munnich","year":"2001","journal-title":"Am J Med Genet"},{"key":"R4-20230918","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1002\/ana.24362","article-title":"Prevalence of nuclear and mitochondrial DNA mutations related to adult mitochondrial disease","volume":"77","author":"Gorman","year":"2015","journal-title":"Ann Neurol"},{"key":"R5-20230918","first-page":"CD004426","article-title":"Treatment for mitochondrial disorders","author":"Pfeffer","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"R7-20230918","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1146\/annurev-pathol-020117-043644","article-title":"Nutritional interventions for mitochondrial OXPHOS deficiencies: mechanisms and model systems","volume":"13","author":"Kuszak","year":"2018","journal-title":"Ann Rev Pathol"},{"key":"R8-20230918","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.ymgme.2018.02.013","article-title":"N-acetylcysteine and vitamin E rescue animal longevity and cellular oxidative stress in preclinical models of mitochondrial complex I disease","volume":"123","author":"Polyak","year":"2018","journal-title":"Mol Genet Metab"},{"key":"R9-20230918","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.ymgme.2016.09.002","article-title":"Nutritional interventions in primary mitochondrial disorders: developing an evidence base","volume":"119","author":"Camp","year":"2016","journal-title":"Mol Genet Metab"},{"key":"R10-20230918","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1038\/gim.2014.177","article-title":"Diagnosis and management of mitochondrial disease: a consensus statement from the Mitochondrial Medicine Society","volume":"17","author":"Parikh","year":"2015","journal-title":"Genet Med"},{"key":"R11-20230918","doi-asserted-by":"crossref","DOI":"10.1038\/gim.2017.107","article-title":"Patient care standards for primary mitochondrial disease: a consensus statement from the Mitochondrial Medicine Society","volume":"19","author":"Parikh","year":"2017","journal-title":"Genet Med"},{"key":"R12-20230918","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1007\/s11940-009-0046-0","article-title":"A modern approach to the treatment of mitochondrial disease","volume":"11","author":"Parikh","year":"2009","journal-title":"Curr Treat Options Neurol"},{"key":"R13-20230918","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.ymgme.2018.01.010","article-title":"8-year retrospective analysis of intravenous arginine therapy for acute metabolic strokes in pediatric mitochondrial disease","volume":"123","author":"Ganetzky","year":"2018","journal-title":"Mol Genet Metab"},{"key":"R14-20230918","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1097\/MCO.0000000000000610","article-title":"Arginine therapy in mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes","volume":"23","author":"Ikawa","year":"2020","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"R15-20230918","doi-asserted-by":"crossref","first-page":"232640981769739","DOI":"10.1177\/2326409817697399","article-title":"Arginine and citrulline for the treatment of MELAS syndrome","volume":"5","author":"El-Hattab","year":"2017","journal-title":"J Inborn Errors Metab Screen"},{"key":"R16-20230918","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1136\/jnnp-2018-317964","article-title":"Taurine supplementation for prevention of stroke-like episodes in MELAS: a multicentre, open-label, 52-week phase III trial","volume":"90","author":"Ohsawa","year":"2019","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R17-20230918","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1001\/archophthalmol.2010.32","article-title":"Clinical trial of lutein in patients with retinitis pigmentosa receiving vitamin A","volume":"128","author":"Berson","year":"2010","journal-title":"Arch Ophthalmol"},{"key":"R18-20230918","doi-asserted-by":"crossref","first-page":"10.3390\/nu10091321","DOI":"10.3390\/nu10091321","article-title":"The effect of lutein on eye and extra-eye health","volume":"10","author":"Buscemi","year":"2018","journal-title":"Nutrients"},{"key":"R19-20230918","doi-asserted-by":"crossref","first-page":"e0180280","DOI":"10.1371\/journal.pone.0180280","article-title":"Phase I randomized clinical trial of N-acetylcysteine in combination with an adjuvant probenecid for treatment of severe traumatic brain injury in children","volume":"12","author":"Clark","year":"2017","journal-title":"PLoS One"},{"key":"R20-20230918","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1046\/j.1365-2362.2000.00736.x","article-title":"N-acetylcysteine replenishes glutathione in HIV infection","volume":"30","author":"De Rosa","year":"2000","journal-title":"Eur J Clin Invest"},{"key":"R21-20230918","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1172\/JCI132990","article-title":"Oral N-acetylcysteine improves cone function in retinitis pigmentosa patients in phase I trial","volume":"130","author":"Campochiaro","year":"2020","journal-title":"J Clin Invest"},{"key":"R22-20230918","doi-asserted-by":"crossref","first-page":"e457","DOI":"10.4088\/JCP.15r09984","article-title":"N-acetylcysteine in depressive symptoms and functionality","volume":"77","author":"Fernandes","year":"2016","journal-title":"J Clin Psychiatry"},{"key":"R23-20230918","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1111\/acps.12862","article-title":"N-acetylcysteine for major mental disorders: a systematic review and meta-analysis of randomized controlled trials","volume":"137","author":"Zheng","year":"2018","journal-title":"Acta Psychiatr Scand"},{"key":"R24-20230918","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2018\/2469486","article-title":"N-acetylcysteine for the treatment of psychiatric disorders: a review of current evidence","volume":"2018","author":"Ooi","year":"2018","journal-title":"Biomed Res Int"},{"key":"R25-20230918","doi-asserted-by":"crossref","first-page":"e11","DOI":"10.1093\/brain\/aww303","article-title":"Treatable mitochondrial diseases: cofactor metabolism and beyond","volume":"140","author":"Distelmaier","year":"2017","journal-title":"Brain"},{"key":"R26-20230918","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.mito.2013.07.116","article-title":"Practice patterns of mitochondrial disease physicians in North America. Part 1: Diagnostic and clinical challenges","volume":"14","author":"Parikh","year":"2014","journal-title":"Mitochondrion"},{"key":"R27-20230918","doi-asserted-by":"crossref","DOI":"10.3390\/jcm6050052","article-title":"Riboflavin responsive mitochondrial dysfunction in neurodegenerative diseases","volume":"6","author":"Udhayabanu","year":"2017","journal-title":"J Clin Med"},{"key":"R28-20230918","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.bbabio.2005.11.009","article-title":"Riboflavin enhances the assembly of mitochondrial cytochrome c oxidase in C. elegans NADH-ubiquinone oxidoreductase mutants","volume":"1757","author":"Grad","year":"2006","journal-title":"Biochim Biophys Acta"},{"key":"R29-20230918","doi-asserted-by":"crossref","first-page":"e69282","DOI":"10.1371\/journal.pone.0069282","article-title":"Primary respiratory chain disease causes tissue-specific dysregulation of the global transcriptome and nutrient-sensing signaling network","volume":"8","author":"Zhang","year":"2013","journal-title":"PLoS One"},{"key":"R30-20230918","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.mito.2015.02.005","article-title":"Pharmacologic targeting of sirtuin and PPAR signaling improves longevity and mitochondrial physiology in respiratory chain complex I mutant Caenorhabditis elegans","volume":"22","author":"McCormack","year":"2015","journal-title":"Mitochondrion"},{"key":"R31-20230918","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1007\/s00018-012-1096-0","article-title":"Structure and function of biotin-dependent carboxylases","volume":"70","author":"Tong","year":"2013","journal-title":"Cell Mol Life Sci"},{"key":"R32-20230918","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1093\/jn\/127.9.1776","article-title":"Lipoic acid reduces the activities of biotin-dependent carboxylases in rat liver","volume":"127","author":"Zempleni","year":"1997","journal-title":"J Nutr"},{"key":"R33-20230918","doi-asserted-by":"crossref","first-page":"16372","DOI":"10.1074\/jbc.M114.622555","article-title":"Interaction of \u03b1-lipoic acid with the human Na+\/multivitamin transporter (hSMVT)","volume":"290","author":"Zehnpfennig","year":"2015","journal-title":"J Biol Chem"},{"key":"R34-20230918","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/8904_2016_529","article-title":"Treatment with mefolinate (5-methyltetrahydrofolate), but not folic acid or folinic acid, leads to measurable 5-methyltetrahydrofolate in cerebrospinal fluid in methylenetetrahydrofolate reductase deficiency","volume":"29","author":"Knowles","year":"2016","journal-title":"JIMD Rep"},{"key":"R35-20230918","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1016\/j.drudis.2015.07.002","article-title":"Can folic acid have a role in mitochondrial disorders?","volume":"20","author":"Ormazabal","year":"2015","journal-title":"Drug Discov Today"},{"key":"R36-20230918","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.ymgme.2009.08.005","article-title":"Cerebral folate deficiency and CNS inflammatory markers in Alpers disease","volume":"99","author":"Hasselmann","year":"2010","journal-title":"Mol Genet Metab"},{"key":"R37-20230918","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1002\/ana.20746","article-title":"Cerebral folate deficiency and leukoencephalopathy caused by a mitochondrial DNA deletion","volume":"59","author":"Pineda","year":"2006","journal-title":"Ann Neurol"},{"key":"R38-20230918","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1186\/s13023-014-0217-2","article-title":"Follow-up of folinic acid supplementation for patients with cerebral folate deficiency and Kearns-Sayre syndrome","volume":"9","author":"Quijada-Fraile","year":"2014","journal-title":"Orphanet J Rare Dis"},{"key":"R39-20230918","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1007\/s10545-018-0224-x","article-title":"Cerebrospinal fluid monoamines, pterins, and folate in patients with mitochondrial diseases: systematic review and hospital experience","volume":"41","author":"Batllori","year":"2018","journal-title":"J Inherit Metab Dis"},{"key":"R40-20230918","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1055\/s-2007-991150","article-title":"Mitochondrial complex I encephalomyopathy and cerebral 5-methyltetrahydrofolate deficiency","volume":"38","author":"Ramaekers","year":"2007","journal-title":"Neuropediatrics"},{"key":"R41-20230918","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1002\/hlca.201500124","article-title":"In vitro antioxidant activity of ubiquinone and ubiquinol, compared to vitamin E","volume":"99","author":"Cervellati","year":"2016","journal-title":"Helv Chim Acta"},{"key":"R42-20230918","doi-asserted-by":"crossref","first-page":"2900","DOI":"10.3390\/nu11122900","article-title":"Vitamin E supplementation and mitochondria in experimental and functional hyperthyroidism: a mini-review","volume":"11","author":"Napolitano","year":"2019","journal-title":"Nutrients"},{"key":"R43-20230918","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.mam.2006.12.009","article-title":"Modulation of signal transduction by vitamin E","volume":"28","author":"Zingg","year":"2007","journal-title":"Mol Aspects Med"},{"key":"R44-20230918","first-page":"855","article-title":"Alpha-tocopherol: looking beyond an antioxidant","volume":"15","author":"Engin","year":"2009","journal-title":"Mol Vis"},{"key":"R45-20230918","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/0891-5849(95)00017-R","article-title":"Alpha-lipoic acid as a biological antioxidant","volume":"19","author":"Packer","year":"1995","journal-title":"Free Radic Biol Med"},{"key":"R46-20230918","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/j.bbagen.2009.07.026","article-title":"Alpha-lipoic acid as a dietary supplement: molecular mechanisms and therapeutic potential","volume":"1790","author":"Shay","year":"2009","journal-title":"Biochim Biophys Acta"},{"key":"R47-20230918","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1007\/s00011-017-1079-6","article-title":"Biochemical and clinical relevance of alpha lipoic acid: antioxidant and anti-inflammatory activity, molecular pathways and therapeutic potential","volume":"66","author":"Tibullo","year":"2017","journal-title":"Inflamm Res"},{"key":"R48-20230918","doi-asserted-by":"crossref","first-page":"4879","DOI":"10.1073\/pnas.87.12.4879","article-title":"Ubiquinol-10 is an effective lipid-soluble antioxidant at physiological concentrations","volume":"87","author":"Frei","year":"1990","journal-title":"Proc Natl Acad Sci"},{"key":"R49-20230918","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.bbagen.2012.01.006","article-title":"CoQ10 deficiencies and MNGIE: Two treatable mitochondrial disorders","volume":"1820","author":"Hirano","year":"2012","journal-title":"Biochim Biophys Acta - Gen Subj"},{"key":"R50-20230918","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1042\/EBC20170114","article-title":"Emerging therapies for mitochondrial diseases","volume":"62","author":"Hirano","year":"2018","journal-title":"Essays Biochem"},{"key":"R51-20230918","first-page":"1","article-title":"Therapeutic effects of idebenone on leber hereditary optic neuropathy","author":"Zhao","year":"2020","journal-title":"Curr Eye Res"},{"key":"R52-20230918","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.coph.2007.04.005","article-title":"N-Acetylcysteine\u2014a safe antidote for cysteine\/glutathione deficiency","volume":"7","author":"Atkuri","year":"2007","journal-title":"Curr Opin Pharmacol"},{"key":"R53-20230918","doi-asserted-by":"crossref","first-page":"50","DOI":"10.3390\/jcm6050050","article-title":"Glutathione as a redox biomarker in mitochondrial disease-implications for therapy","volume":"6","author":"Enns","year":"2017","journal-title":"J Clin Med"},{"key":"R54-20230918","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1177\/0271678X18765828","article-title":"N-Acetylcysteine rapidly replenishes central nervous system glutathione measured via magnetic resonance spectroscopy in human neonates with hypoxic-ischemic encephalopathy","volume":"38","author":"Moss","year":"2018","journal-title":"J Cereb Blood Flow Metab Off J Int Soc Cereb Blood Flow Metab"},{"key":"R55-20230918","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.ymgmr.2018.03.001","article-title":"Microvascular endothelial dysfunction in mitochondrial stroke-like episodes supports use of intravenous L-arginine","volume":"15","author":"Ganetzky","year":"2018","journal-title":"Mol Genet Metab Reports"},{"key":"R56-20230918","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.ymgme.2012.01.016","article-title":"Restoration of impaired nitric oxide production in MELAS syndrome with citrulline and arginine supplementation","volume":"105","author":"El-Hattab","year":"2012","journal-title":"Mol Genet Metab"},{"key":"R57-20230918","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.ymgme.2012.06.018","article-title":"Citrulline and arginine utility in treating nitric oxide deficiency in mitochondrial disorders","volume":"107","author":"El-Hattab","year":"2012","journal-title":"Mol Genet Metab"},{"key":"R58-20230918","doi-asserted-by":"crossref","first-page":"e011037","DOI":"10.1161\/JAHA.118.011037","article-title":"Carnitine is associated with atherosclerotic risk and myocardial infarction in HIV-infected adults","volume":"8","author":"Sinha","year":"2019","journal-title":"J Am Heart Assoc"},{"key":"R59-20230918","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.atherosclerosis.2013.10.013","article-title":"Gut microbiota metabolism of L-carnitine and cardiovascular risk","volume":"231","author":"Ussher","year":"2013","journal-title":"Atherosclerosis"},{"key":"R60-20230918","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.ymgme.2014.04.008","article-title":"Efficacy of pyruvate therapy in patients with mitochondrial disease: a semi-quantitative clinical evaluation study","volume":"112","author":"Fujii","year":"2014","journal-title":"Mol Genet Metab"},{"issue":"(Suppl 1)","key":"R61-20230918","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.1186\/1423-0127-17-S1-S23","article-title":"A role for taurine in mitochondrial function","volume":"17","author":"Hansen","year":"2010","journal-title":"J Biomed Sci"},{"key":"R62-20230918","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1002\/mus.20688","article-title":"Beneficial effects of creatine, CoQ10, and lipoic acid in mitochondrial disorders","volume":"35","author":"Rodriguez","year":"2007","journal-title":"Muscle Nerve"},{"key":"R63-20230918","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1007\/s12311-017-0846-9","article-title":"Three-year follow-up of high-dose ubiquinol supplementation in a case of familial multiple system atrophy with compound heterozygous COQ2 mutations","volume":"16","author":"Mitsui","year":"2017","journal-title":"Cerebellum"},{"key":"R64-20230918","doi-asserted-by":"crossref","DOI":"10.3390\/biology8020028","article-title":"CoQ10 and aging","volume":"8","author":"Barcelos","year":"2019","journal-title":"Biology"},{"key":"R65-20230918","first-page":"1743","article-title":"Anaphylaxis to parenteral thiamine (vitamin B1)","volume":"128","author":"Morinville","year":"1998","journal-title":"Schweiz Med Wochenschr"},{"key":"R66-20230918","doi-asserted-by":"crossref","first-page":"9113","DOI":"10.1073\/pnas.87.23.9113","article-title":"G protein diversity: a distinct class of alpha subunits is present in vertebrates and invertebrates","volume":"87","author":"Strathmann","year":"1990","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R68-20230918","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1016\/0016-5085(93)90652-S","article-title":"Multicenter trial of d-alpha-tocopheryl polyethylene glycol 1000 succinate for treatment of vitamin E deficiency in children with chronic cholestasis","volume":"104","author":"Sokol","year":"1993","journal-title":"Gastroenterology"},{"key":"R69-20230918","doi-asserted-by":"crossref","first-page":"37","DOI":"10.7326\/0003-4819-142-1-200501040-00110","article-title":"Meta-analysis: high-dosage vitamin E supplementation may increase all-cause mortality","volume":"142","author":"Miller","year":"2005","journal-title":"Ann Intern Med"},{"key":"R70-20230918","doi-asserted-by":"crossref","first-page":"456279","DOI":"10.1155\/2012\/456279","article-title":"Alpha lipoic Acid for symptomatic peripheral neuropathy in patients with diabetes: a meta-analysis of randomized controlled trials","volume":"2012","author":"Mijnhout","year":"2012","journal-title":"Int J Endocrinol"},{"key":"R71-20230918","doi-asserted-by":"crossref","first-page":"e635","DOI":"10.4317\/medoral.16942","article-title":"Combination of alpha lipoic acid and gabapentin, its efficacy in the treatment of Burning Mouth Syndrome: a randomized, double-blind, placebo controlled trial","volume":"16","author":"L\u00f3pez-D\u2019alessandro","year":"2011","journal-title":"Med Oral Patol Oral Cir Bucal"},{"key":"R72-20230918","doi-asserted-by":"crossref","first-page":"25","DOI":"10.7453\/gahmj.2013.011","article-title":"Adverse effects of high doses of intravenous alpha lipoic acid on liver mitochondria","volume":"3","author":"Vigil","year":"2014","journal-title":"Glob Adv Heal Med"},{"key":"R73-20230918","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1007\/s11940-014-0292-7","article-title":"Treatment of mitochondrial disorders","volume":"16","author":"Avula","year":"2014","journal-title":"Curr Treat Options Neurol"},{"key":"R74-20230918","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.amjmed.2010.08.005","article-title":"Effects of alpha-lipoic Acid on body weight in obese subjects","volume":"124","author":"Koh","year":"2011","journal-title":"Am J Med"},{"key":"R75-20230918","first-page":"12","article-title":"Glycemic and oxidative status of patients with type 2 diabetes mellitus following oral administration of alpha-lipoic acid: a randomized double-blinded placebo-controlled study","volume":"21","author":"Porasuphatana","year":"2012","journal-title":"Asia Pac J Clin Nutr"},{"key":"R76-20230918","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1111\/j.1365-2362.2009.02236.x","article-title":"Alpha-lipoic acid improves vascular endothelial function in patients with type 2 diabetes: a placebo-controlled randomized trial","volume":"40","author":"Heinisch","year":"2010","journal-title":"Eur J Clin Invest"},{"key":"R77-20230918","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1177\/0091270004270792","article-title":"Pharmacokinetics of alpha-lipoic acid in subjects with severe kidney damage and end-stage renal disease","volume":"45","author":"Teichert","year":"2005","journal-title":"J Clin Pharmacol"},{"key":"R78-20230918","doi-asserted-by":"crossref","first-page":"369","DOI":"10.2337\/diacare.20.3.369","article-title":"Effects of treatment with the antioxidant alpha-lipoic acid on cardiac autonomic neuropathy in NIDDM patients. A 4-month randomized controlled multicenter trial (DEKAN Study). Deutsche Kardiale Autonome Neuropathie","volume":"20","author":"Ziegler","year":"1997","journal-title":"Diabetes Care"},{"key":"R79-20230918","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1007\/s11255-014-0688-z","article-title":"Effects of alpha lipoic acid supplementation on serum levels of IL-8 and TNF-\u03b1 in patient with ESRD undergoing hemodialysis","volume":"46","author":"Safa","year":"2014","journal-title":"Int Urol Nephrol"},{"key":"R80-20230918","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.ymgme.2008.09.006","article-title":"Management of a patient with holocarboxylase synthetase deficiency","volume":"95","author":"Van Hove","year":"2008","journal-title":"Mol Genet Metab"},{"key":"R82-20230918","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0022-3476(83)80351-5","article-title":"Phenotypic variation in biotinidase deficiency","volume":"103","author":"Wolf","year":"1983","journal-title":"J Pediatr"},{"key":"R83-20230918","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1093\/ajcn\/69.3.504","article-title":"Bioavailability of biotin given orally to humans in pharmacologic doses","volume":"69","author":"Zempleni","year":"1999","journal-title":"Am J Clin Nutr"},{"key":"R84-20230918","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.pediatrneurol.2007.09.001","article-title":"Folate-responsive neurologic diseases","volume":"37","author":"Djukic","year":"2007","journal-title":"Pediatr Neurol"},{"key":"R85-20230918","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/mp.2016.168","article-title":"Folinic acid improves verbal communication in children with autism and language impairment: a randomized double-blind placebo-controlled trial","volume":"23","author":"Frye","year":"2018","journal-title":"Mol Psychiatry"},{"key":"R86-20230918","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1111\/j.1469-8749.2004.tb00451.x","article-title":"Cerebral folate deficiency","volume":"46","author":"Ramaekers","year":"2004","journal-title":"Dev Med Child Neurol"},{"key":"R87-20230918","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1179\/1973947815Y.0000000048","article-title":"Hypersensitivity reaction caused by folinic acid administration: a case report and literature review","volume":"28","author":"Florit-Sureda","year":"2016","journal-title":"J Chemother"},{"key":"R88-20230918","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1177\/1078155210396577","article-title":"Leucovorin-induced hypersensitivity reaction","volume":"18","author":"Damaske","year":"2012","journal-title":"J Oncol Pharm Pract Off Publ Int Soc Oncol Pharm Pract"},{"key":"R89-20230918","doi-asserted-by":"crossref","first-page":"2861","DOI":"10.1007\/s00415-018-9057-7","article-title":"Therapeutic regimen of l-arginine for MELAS: 9-year, prospective, multicenter, clinical research","volume":"265","author":"Koga","year":"2018","journal-title":"J Neurol"},{"key":"R90-20230918","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1017\/S0007114507841110","article-title":"Dose-ranging effects of citrulline administration on plasma amino acids and hormonal patterns in healthy subjects: the Citrudose pharmacokinetic study","volume":"99","author":"Moinard","year":"2008","journal-title":"Br J Nutr"},{"key":"R91-20230918","doi-asserted-by":"crossref","first-page":"921","DOI":"10.3390\/nu10070921","article-title":"l-Citrulline supplementation: impact on cardiometabolic health","volume":"10","author":"Allerton","year":"2018","journal-title":"Nutrients"},{"key":"R92-20230918","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/j.clnu.2018.02.017","article-title":"Impact of 3-week citrulline supplementation on postprandial protein metabolism in malnourished older patients: the Ciproage randomized controlled trial","volume":"38","author":"Bouillanne","year":"2019","journal-title":"Clin Nutr"},{"key":"R93-20230918","doi-asserted-by":"crossref","first-page":"2643S","DOI":"10.3945\/jn.115.227280","article-title":"The importance of quality specifications in safety assessments of amino acids: the cases of l-tryptophan and l-citrulline","volume":"146","author":"Oketch-Rabah","year":"2016","journal-title":"J Nutr"},{"key":"R94-20230918","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1519\/JSC.0b013e3181cb28e0","article-title":"Citrulline malate enhances athletic anaerobic performance and relieves muscle soreness","volume":"24","author":"P\u00e9rez-Guisado","year":"2010","journal-title":"J Strength Cond Res"},{"key":"R95-20230918","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.yrtph.2006.05.005","article-title":"Risk assessment for creatine monohydrate","volume":"45","author":"Shao","year":"2006","journal-title":"Regul Toxicol Pharmacol RTP"},{"key":"R96-20230918","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1056\/NEJM199903113401017","article-title":"Interstitial nephritis in a patient taking creatine","volume":"340","author":"Koshy","year":"1999","journal-title":"N Engl J Med"},{"key":"R97-20230918","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1001\/jamaophthalmol.2016.4117","article-title":"Crystalline maculopathy associated with high-dose lutein supplementation","volume":"134","author":"Choi","year":"2016","journal-title":"JAMA Ophthalmol"},{"key":"R98-20230918","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1001\/jamaophthalmol.2013.7376","article-title":"Secondary analyses of the effects of lutein\/zeaxanthin on age-related macular degeneration progression: AREDS2 report No. 3","volume":"132","author":"Chew","year":"2014","journal-title":"JAMA Ophthalmol"},{"key":"R99-20230918","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1167\/iovs.06-0764","article-title":"Macular pigment and lutein supplementation in ABCA4-associated retinal degenerations","volume":"48","author":"Aleman","year":"2007","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R100-20230918","volume":"140","author":"Niemi","year":"2012","journal-title":"The role of N-acetylcysteine in treating mitochondrial liver disease"},{"key":"R101-20230918","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1212\/WNL.59.9.1447","article-title":"N-acetylcysteine and Unverricht-Lundborg disease: variable response and possible side effects","volume":"59","author":"Edwards","year":"2002","journal-title":"Neurology"},{"key":"R102-20230918","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.neubiorev.2015.04.015","article-title":"Clinical trials of N-acetylcysteine in psychiatry and neurology: a systematic review","volume":"55","author":"Deepmala","year":"2015","journal-title":"Neurosci Biobehav Rev"},{"key":"R103-20230918","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1007\/s001250051536","article-title":"Safety of high-dose nicotinamide: a review","volume":"43","author":"Knip","year":"2000","journal-title":"Diabetologia"},{"key":"R104-20230918","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1001\/jama.1994.03510330050033","article-title":"A comparison of the efficacy and toxic effects of sustained- vs immediate-release niacin in hypercholesterolemic patients","volume":"271","author":"McKenney","year":"1994","journal-title":"JAMA"},{"key":"R105-20230918","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.braindev.2011.03.003","article-title":"Beneficial effect of pyruvate therapy on Leigh syndrome due to a novel mutation in PDH E1\u03b1 gene","volume":"34","author":"Koga","year":"2012","journal-title":"Brain Dev"},{"key":"R106-20230918","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1152\/jappl.2000.89.2.549","article-title":"Pyruvate ingestion for 7 days does not improve aerobic performance in well trained individuals","volume":"89","author":"Morrison","year":"2000","journal-title":"J Appl Physiol (Bethesda, Md 1985)"},{"key":"R107-20230918","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.mito.2007.07.002","article-title":"Therapeutic potential of pyruvate therapy for mitochondrial diseases","volume":"7","author":"Tanaka","year":"2007","journal-title":"Mitochondrion"},{"key":"R108-20230918","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.ejpn.2017.09.004","article-title":"Mutations in AIFM1 cause an X-linked childhood cerebellar ataxia partially responsive to riboflavin","volume":"22","author":"Heimer","year":"2018","journal-title":"Eur J Paediatr Neurol EJPN Off J Eur Paediatr Neurol Soc"},{"key":"R109-20230918","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1007\/s10545-016-9924-2","article-title":"Clinical presentation and outcome of riboflavin transporter deficiency: mini review after five years of experience","volume":"39","author":"Jaeger","year":"2016","journal-title":"J Inherit Metab Dis"},{"key":"R110-20230918","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/S0022-3476(97)70323-8","article-title":"Mitochondrial myopathy with tRNA(Leu(UUR)) mutation and complex I deficiency responsive to riboflavin","volume":"130","author":"Ogle","year":"1997","journal-title":"J Pediatr"},{"key":"R111-20230918","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1186\/s13023-018-0784-8","article-title":"Clinical, biochemical and genetic spectrum of 70 patients with ACAD9 deficiency: is riboflavin supplementation effective?","volume":"13","author":"Repp","year":"2018","journal-title":"Orphanet J Rare Dis"},{"key":"R112-20230918","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1046\/j.1468-2982.1994.1405328.x","article-title":"High-dose riboflavin as a prophylactic treatment of migraine: results of an open pilot study","volume":"14","author":"Schoenen","year":"1994","journal-title":"Cephalalgia An Int J Headache"},{"key":"R113-20230918","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.nmd.2017.03.003","article-title":"Patient with multiple acyl-CoA dehydrogenation deficiency disease and FLAD1 mutations benefits from riboflavin therapy","volume":"27","author":"Auranen","year":"2017","journal-title":"Neuromuscul Disord NMD"},{"key":"R114-20230918","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1212\/WNL.0000000000006498","article-title":"Child Neurology: Brown-Vialetto-Van Laere syndrome: Dramatic visual recovery after delayed riboflavin therapy","volume":"91","author":"Bamaga","year":"2018","journal-title":"Neurology"},{"key":"R115-20230918","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1111\/j.1468-1331.2004.00813.x","article-title":"High-dose riboflavin treatment is efficacious in migraine prophylaxis: an open study in a tertiary care centre","volume":"11","author":"Boehnke","year":"2004","journal-title":"Eur J Neurol"},{"key":"R116-20230918","first-page":"1383","article-title":"Riboflavin-responsive multiple acyl-CoA dehydrogenase deficiency with unknown genetic defect","volume":"33","author":"Cotelli","year":"2012","journal-title":"Neurol Sci Off J Ital Neurol Soc Ital Soc Clin Neurophysiol"},{"key":"R117-20230918","doi-asserted-by":"crossref","first-page":"471","DOI":"10.4103\/JPN.JPN_131_17","article-title":"Riboflavin treatment in genetically proven Brown-Vialetto-Van Laere Syndrome","volume":"13","author":"Garg","year":"2018","journal-title":"J Pediatr Neurosci"},{"key":"R118-20230918","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1093\/brain\/awq273","article-title":"Riboflavin-responsive oxidative phosphorylation complex I deficiency caused by defective ACAD9: new function for an old gene","volume":"134","author":"Gerards","year":"2011","journal-title":"Brain A J Neurol"},{"key":"R119-20230918","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.braindev.2020.04.002","article-title":"Effectiveness of low-dose riboflavin as a prophylactic agent in pediatric migraine","volume":"42","author":"Yamanaka","year":"2020","journal-title":"Brain Dev"},{"key":"R120-20230918","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1111\/jcpt.12548","article-title":"Prophylaxis of migraine headaches with riboflavin: a systematic review","volume":"42","author":"Thompson","year":"2017","journal-title":"J Clin Pharm Ther"},{"key":"R121-20230918","first-page":"528","article-title":"Accumulation of taurine in patients with renal failure","volume":"17","author":"Suliman","year":"2002","journal-title":"Nephrol Dial Transplant Off Publ Eur Dial Transpl Assoc - Eur Ren Assoc"},{"key":"R122-20230918","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1177\/089198879300600408","article-title":"Preliminary findings of high-dose thiamine in dementia of Alzheimer's type","volume":"6","author":"Meador","year":"1993","journal-title":"J Geriatr Psychiatry Neurol"},{"key":"R123-20230918","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1080\/01616412.2016.1263176","article-title":"Biotin-thiamine-responsive basal ganglia disease: catastrophic consequences of delay in diagnosis and treatment","volume":"39","author":"Algahtani","year":"2017","journal-title":"Neurol Res"},{"key":"R124-20230918","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.ejpn.2015.04.008","article-title":"Pyruvate dehydrogenase deficiency presenting as isolated paroxysmal exercise induced dystonia successfully reversed with thiamine supplementation. Case report and mini-review","volume":"19","author":"Castiglioni","year":"2015","journal-title":"Eur J Paediatr Neurol"},{"key":"R125-20230918","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.ymgmr.2013.12.007","article-title":"Thiamine pyrophosphokinase deficiency causes a Leigh Disease like phenotype in a sibling pair: identification through whole exome sequencing and management strategies","volume":"1","author":"Fraser","year":"2014","journal-title":"Mol Genet Metab Reports"},{"key":"R126-20230918","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1111\/imj.12522","article-title":"Thiamine in the treatment of Wernicke encephalopathy in patients with alcohol use disorders","volume":"44","author":"Latt","year":"2014","journal-title":"Intern Med J"},{"key":"R127-20230918","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.cca.2019.07.034","article-title":"Thiamine phosphokinase deficiency and mutation in TPK1 presenting as biotin responsive basal ganglia disease","volume":"499","author":"Nyhan","year":"2019","journal-title":"Clin Chim Acta"},{"key":"R128-20230918","doi-asserted-by":"crossref","first-page":"4065","DOI":"10.1038\/s41467-018-06250-w","article-title":"Pathogenic variants in glutamyl-tRNAGln amidotransferase subunits cause a lethal mitochondrial cardiomyopathy disorder","volume":"9","author":"Friederich","year":"2018","journal-title":"Nat Commun"},{"key":"R129-20230918","article-title":"Biotinidase deficiency","author":"Wolf","year":"1993","journal-title":"GeneReviews\u00ae [Internet]"},{"key":"R130-20230918","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/1750-1172-7-83","article-title":"The Brown-Vialetto-Van Laere and Fazio Londe syndrome revisited: natural history, genetics, treatment and future perspectives","volume":"7","author":"Bosch","year":"2012","journal-title":"Orphanet J Rare Dis"},{"key":"R131-20230918","article-title":"Primary coenzyme Q10 deficiency","author":"Salviati","year":"1993","journal-title":"GeneReviews\u00ae"},{"key":"R132-20230918","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1750-1172-7-21","article-title":"Copper and bezafibrate cooperate to rescue cytochrome c oxidase deficiency in cells of patients with SCO2 mutations","volume":"7","author":"Casarin","year":"2012","journal-title":"Orphanet J Rare Dis"},{"key":"R133-20230918","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1023\/B:BOLI.0000016614.47380.2f","article-title":"Reversion of hypertrophic cardiomyopathy in a patient with deficiency of the mitochondrial copper binding protein Sco2: is there a potential effect of copper?","volume":"27","author":"Freisinger","year":"2004","journal-title":"J Inherit Metab Dis"},{"key":"R134-20230918","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1016\/j.celrep.2018.10.036","article-title":"A screen using iPSC-derived hepatocytes reveals NAD+ as a potential treatment for mtDNA depletion syndrome","volume":"25","author":"Jing","year":"2018","journal-title":"Cell Rep"},{"key":"R135-20230918","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1002\/ajmg.a.61074","article-title":"Case report and novel treatment of an autosomal recessive Leigh syndrome caused by short-chain enoyl-CoA hydratase deficiency","volume":"179","author":"Shayota","year":"2019","journal-title":"Am J Med Genet A"},{"key":"R136-20230918","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s12887-020-1947-z","article-title":"Clinical, biochemical and metabolic characterization of patients with short-chain enoyl-CoA hydratase(ECHS1) deficiency: two case reports and the review of the literature","volume":"20","author":"Yang","year":"2020","journal-title":"BMC Pediatr"},{"key":"R137-20230918","article-title":"Mitochondrial short-chain enoyl-CoA hydratase 1 deficiency","author":"Ganetzky","year":"1993","journal-title":"GeneReviews\u00ae"},{"key":"R138-20230918","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.pediatrneurol.2014.10.023","article-title":"Identification of HIBCH gene mutations causing autosomal recessive Leigh syndrome: a gene involved in valine metabolism","volume":"52","author":"Soler-Alfonso","year":"2015","journal-title":"Pediatr Neurol"},{"key":"R139-20230918","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.ymgmr.2014.10.003","article-title":"Clinical and biochemical characterization of 3-hydroxyisobutyryl-CoA hydrolase (HIBCH) deficiency that causes Leigh-like disease and ketoacidosis","volume":"1","author":"Yamada","year":"2014","journal-title":"Mol Genet Metab Reports"},{"key":"R140-20230918","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/s11011-016-9928-5","article-title":"Successful treatment of a patient with ethylmalonic encephalopathy by intravenous N-acetylcysteine","volume":"32","author":"K\u0131l\u0131\u00e7","year":"2017","journal-title":"Metab Brain Dis"},{"key":"R141-20230918","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1038\/nm.2188","article-title":"Combined treatment with oral metronidazole and N-acetylcysteine is effective in ethylmalonic encephalopathy","volume":"16","author":"Viscomi","year":"2010","journal-title":"Nat Med"},{"key":"R142-20230918","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.ymgme.2018.02.008","article-title":"Response to medical and a novel dietary treatment in newborn screen identified patients with ethylmalonic encephalopathy","volume":"124","author":"Boyer","year":"2018","journal-title":"Mol Genet Metab"},{"key":"R143-20230918","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1016\/j.ajhg.2016.04.006","article-title":"Riboflavin-responsive and -nonresponsive mutations in FAD synthase cause multiple acyl-CoA dehydrogenase and combined respiratory-chain deficiency","volume":"98","author":"Olsen","year":"2016","journal-title":"Am J Hum Genet"},{"key":"R144-20230918","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.ajhg.2019.07.015","article-title":"Bi-allelic GOT2 mutations cause a treatable malate-aspartate shuttle-related encephalopathy","volume":"105","author":"van Karnebeek","year":"2019","journal-title":"Am J Hum Genet"},{"key":"R145-20230918","doi-asserted-by":"crossref","first-page":"106546","DOI":"10.1016\/j.yebeh.2019.106546","article-title":"Advances in the treatment of mitochondrial epilepsies","volume":"101","author":"Rahman","year":"2019","journal-title":"Epilepsy Behav"},{"key":"R146-20230918","article-title":"Multiple Acyl-CoA dehydrogenase deficiency","author":"Prasun","year":"1993","journal-title":"GeneReviews\u00ae"},{"key":"R147-20230918","article-title":"MELAS","author":"El-Hattab","year":"1993","journal-title":"GeneReviews\u00ae"},{"key":"R148-20230918","article-title":"Mitochondrial DNA maintenance defects overview","author":"El-Hattab","year":"1993","journal-title":"GeneReviews\u00ae"},{"key":"R149-20230918","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/s10545-016-0011-5","article-title":"Ketogenic diet in pyruvate dehydrogenase complex deficiency: short- and long-term outcomes","volume":"40","author":"Sofou","year":"2017","journal-title":"J Inherit Metab Dis"},{"key":"R150-20230918","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.mito.2014.09.006","article-title":"Riboflavin responsive mitochondrial myopathy is a new phenotype of dihydrolipoamide dehydrogenase deficiency. The chaperon-like effect of vitamin B2","volume":"18","author":"Carrozzo","year":"2014","journal-title":"Mitochondrion"},{"key":"R151-20230918","doi-asserted-by":"crossref","first-page":"100453","DOI":"10.1016\/j.ymgmr.2019.100453","article-title":"L-Cysteine supplementation prevents liver transplantation in a patient with TRMU deficiency","volume":"19","author":"Soler-Alfonso","year":"2019","journal-title":"Mol Genet Metab Reports"},{"key":"R152-20230918","doi-asserted-by":"crossref","first-page":"301","DOI":"10.3390\/cells9020301","article-title":"Bezafibrate improves mitochondrial fission and function in DNM1L-deficient patient cells","volume":"9","author":"Douiev","year":"2020","journal-title":"Cells"},{"key":"R153-20230918","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1016\/j.cmet.2020.04.008","article-title":"Niacin cures systemic NAD+ deficiency and improves muscle performance in adult-onset mitochondrial myopathy","volume":"31","author":"Pirinen","year":"2020","journal-title":"Cell Metab"}],"container-title":["Current Opinion in Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MOP.0000000000000954","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,17]],"date-time":"2023-09-17T22:37:07Z","timestamp":1694990227000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MOP.0000000000000954"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,23]]},"references-count":149,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/mop.0000000000000954","relation":{},"ISSN":["1040-8703","1531-698X"],"issn-type":[{"value":"1040-8703","type":"print"},{"value":"1531-698X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,23]]}}}